Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer

被引:38
作者
Berndt, Alexander [1 ]
Richter, Petra [1 ]
Kosmehl, Hartwig [2 ]
Franz, Marcus [3 ]
机构
[1] Jena Univ Hosp, Inst Pathol, Jena, Germany
[2] HELIOS Klinikum Erfurt, Inst Pathol, Erfurt, Germany
[3] Jena Univ Hosp, Dept Internal Med 1, Jena, Germany
关键词
alternative splicing; carcinoma invasion; ECM reorganization; oral squamous cell carcinoma; tenascin-C; urothelial carcinoma of the urinary bladder; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX COMPONENTS; HUMAN BREAST-CANCER; PRE-MESSENGER-RNA; IN-SITU; ALPHA-V-BETA-6; INTEGRIN; PROGNOSTIC-SIGNIFICANCE; PROTEIN DISTRIBUTION; EXPRESSION; IDENTIFICATION;
D O I
10.1080/19336918.2015.1005463
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Carcinoma invasion is a complex process regulated by genetic and epigenetic factors as well. A relevant supportive condition for cancer cell migration is the reorganization of the extracellular matrix (ECM), which is realized in an orchestrated multicellular manner including carcinoma cells and stromal fibroblasts. An important key player in the process of ECM reorganization is Tenascin-C (Tn-C). The molecule occurs as different isoforms generated by alternative splicing and de novo glycosylation. Large variants of Tn-C are abundantly re-expressed in the invasive front of many carcinoma types. A special role for initiating migration and accompanied epithelial to mesenchymal transition has been suggested. Here, we review the current knowledge concerning the tumor biological importance of Tn-C, the synthesis and alternative splicing during the invasive process in general, and give an overview on the impact of Tn-C in urothelial carcinoma of the urinary bladder (UBC) and oral squamous cell carcinoma (OSCC).
引用
收藏
页码:105 / 111
页数:7
相关论文
共 89 条
[1]
Adams M, 2002, CANCER RES, V62, P3289
[2]
Atula T, 2003, ANTICANCER RES, V23, P3051
[3]
PURIFICATION OF HEXABRACHION (TENASCIN) FROM CELL-CULTURE CONDITIONED MEDIUM, AND SEPARATION FROM A CELL-ADHESION FACTOR [J].
AUKHIL, I ;
SLEMP, CC ;
LIGHTNER, VA ;
NISHIMURA, K ;
BRISCOE, G ;
ERICKSON, HP .
MATRIX, 1990, 10 (02) :98-111
[4]
β-Catenin regulates the expression of tenascin-C in human colorectal tumors [J].
Beiter, K ;
Hiendlmeyer, E ;
Brabletz, T ;
Hlubek, F ;
Haynl, A ;
Knoll, C ;
Kirchner, T ;
Jung, A .
ONCOGENE, 2005, 24 (55) :8200-8204
[5]
Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder [J].
Berndt, A ;
Anger, K ;
Richter, P ;
Borsi, L ;
Brack, S ;
Silacci, M ;
Franz, M ;
Wunderlich, H ;
Gajda, M ;
Zardi, L ;
Neri, D ;
Kosmehl, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (08) :537-546
[6]
Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro [J].
Berndt, A ;
Borsi, L ;
Hyckel, P ;
Kosmehl, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (05) :286-292
[7]
A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies [J].
Berndt, Alexander ;
Koellner, Robert ;
Richter, Petra ;
Franz, Marcus ;
Voigt, Astrid ;
Berndt, Angela ;
Borsi, Laura ;
Giavazzi, RaVaella ;
Neri, Dario ;
Kosmehl, Hartwig .
HISTOCHEMISTRY AND CELL BIOLOGY, 2010, 133 (04) :467-475
[8]
Towards defining roles and relationships for tenascin-C and TGFβ-1 in the normal and neoplastic urinary bladder [J].
Booth, C ;
Harnden, P ;
Selby, PJ ;
Southgate, J .
JOURNAL OF PATHOLOGY, 2002, 198 (03) :359-368
[9]
CELL-CYCLE DEPENDENT ALTERNATIVE SPLICING OF THE TENASCIN PRIMARY TRANSCRIPT [J].
BORSI, L ;
BALZA, E ;
CASTELLANI, P ;
CARNEMOLLA, B ;
PONASSI, M ;
QUERZE, G ;
ZARDI, L .
CELL ADHESION AND COMMUNICATION, 1994, 1 (04) :307-317
[10]
Borsi L, 1996, INT J CANCER, V66, P632, DOI 10.1002/(SICI)1097-0215(19960529)66:5<632::AID-IJC9>3.0.CO